Status:
COMPLETED
Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED)
Lead Sponsor:
H. Lundbeck A/S
Conditions:
Insomnia
Eligibility:
All Genders
18-64 years
Phase:
PHASE3
Brief Summary
The purpose of this trial is to study the safety and effectiveness of MK0928 for adults with insomnia.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosis of insomnia
Exclusion
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
End Date :
February 1 2007
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00095069
Start Date
October 1 2004
End Date
February 1 2007
Last Update
January 14 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.